These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27011018)

  • 1. High Sequence Variability of the ppE18 Gene of Clinical Mycobacterium tuberculosis Complex Strains Potentially Impacts Effectivity of Vaccine Candidate M72/AS01E.
    Homolka S; Ubben T; Niemann S
    PLoS One; 2016; 11(3):e0152200. PubMed ID: 27011018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA polymorphisms in the pepA and PPE18 genes among clinical strains of Mycobacterium tuberculosis: implications for vaccine efficacy.
    Hebert AM; Talarico S; Yang D; Durmaz R; Marrs CF; Zhang L; Foxman B; Yang Z
    Infect Immun; 2007 Dec; 75(12):5798-805. PubMed ID: 17893137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins.
    Xiang ZH; Sun RF; Lin C; Chen FZ; Mai JT; Liu YX; Xu ZY; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():226. PubMed ID: 28620588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homoplastic single nucleotide polymorphisms contributed to phenotypic diversity in Mycobacterium tuberculosis.
    Tantivitayakul P; Ruangchai W; Juthayothin T; Smittipat N; Disratthakit A; Mahasirimongkol S; Viratyosin W; Tokunaga K; Palittapongarnpim P
    Sci Rep; 2020 May; 10(1):8024. PubMed ID: 32415151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Systematic Review and Meta-Analysis on the Immunogenicity and Safety of the Tuberculosis Subunit Vaccines M72/AS01
    Ullah I; Bibi S; Ul Haq I; Safia ; Ullah K; Ge L; Shi X; Bin M; Niu H; Tian J; Zhu B
    Front Immunol; 2020; 11():1806. PubMed ID: 33133057
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting.
    Penn-Nicholson A; Geldenhuys H; Burny W; van der Most R; Day CL; Jongert E; Moris P; Hatherill M; Ofori-Anyinam O; Hanekom W; ; Bollaerts A; Demoitie MA; Kany Luabeya AK; De Ruymaeker E; Tameris M; Lapierre D; Scriba TJ
    Vaccine; 2015 Jul; 33(32):4025-34. PubMed ID: 26072017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PPE18 of Mycobacterium tuberculosis interacts with TLR2 and activates IL-10 induction in macrophage.
    Nair S; Ramaswamy PA; Ghosh S; Joshi DC; Pathak N; Siddiqui I; Sharma P; Hasnain SE; Mande SC; Mukhopadhyay S
    J Immunol; 2009 Nov; 183(10):6269-81. PubMed ID: 19880448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RD5-mediated lack of PE_PGRS and PPE-MPTR export in BCG vaccine strains results in strong reduction of antigenic repertoire but little impact on protection.
    Ates LS; Sayes F; Frigui W; Ummels R; Damen MPM; Bottai D; Behr MA; van Heijst JWJ; Bitter W; Majlessi L; Brosch R
    PLoS Pathog; 2018 Jun; 14(6):e1007139. PubMed ID: 29912964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines.
    Romano M; Aryan E; Korf H; Bruffaerts N; Franken CL; Ottenhoff TH; Huygen K
    Microbes Infect; 2012 Jan; 14(1):86-95. PubMed ID: 21920450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro-American genetic background confers optimal vaccine potential.
    Pérez I; Uranga S; Sayes F; Frigui W; Samper S; Arbués A; Aguiló N; Brosch R; Martín C; Gonzalo-Asensio J
    EBioMedicine; 2020 May; 55():102761. PubMed ID: 32361249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines.
    Tyne AS; Chan JG; Shanahan ER; Atmosukarto I; Chan HK; Britton WJ; West NP
    Vaccine; 2013 Sep; 31(40):4322-9. PubMed ID: 23880366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice.
    Li W; Deng G; Li M; Zeng J; Zhao L; Liu X; Wang Y
    Mol Immunol; 2014 Nov; 62(1):86-95. PubMed ID: 24980867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservation in gene encoding Mycobacterium tuberculosis antigen Rv2660 and a high predicted population coverage of H56 multistage vaccine in South Africa.
    Perez-Martinez AP; Ong E; Zhang L; Marrs CF; He Y; Yang Z
    Infect Genet Evol; 2017 Nov; 55():244-250. PubMed ID: 28941991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and Safety of the M72/AS01
    Ji Z; Jian M; Chen T; Luo L; Li L; Dai X; Bai R; Ding Z; Bi Y; Wen S; Zhou G; Abi ME; Liu A; Bao F
    Front Immunol; 2019; 10():2089. PubMed ID: 31552037
    [No Abstract]   [Full Text] [Related]  

  • 18. New multistage TB vaccine shown to produce stronger, longer-lasting response against Mycobacterium tuberculosis.
    Immunotherapy; 2011 Mar; 3(3):309. PubMed ID: 21395372
    [No Abstract]   [Full Text] [Related]  

  • 19. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
    Wu M; Li M; Yue Y; Xu W
    Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
    Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
    J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.